Brief: Heat Biologics Inc says It Had Cash, Cash Equivalents And Short-Term Investments Of $35.5 Million As Of June 1, 2020
June 1 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS INC - IT HAD CASH, CASH EQUIVALENTS AND
SHORT-TERM INVESTMENTS OF $35.5 MILLION AS OF JUNE 1, 2020
* HEAT BIOLOGICS - BELIEVES IT HAS SUFFICIENT CASH TO FUND
OPERATIONS AND CURRENT AND PLANNED CLINICAL ACTIVITIES INTO Q1
OF 2022
Source text - https://bit.ly/2yRZOOM
Further company coverage: HTBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company